The epidermal growth factor receptor axis: Support for a new target for oral premalignancy

Miriam P. Rosin, Joseph A. Califano

Research output: Contribution to journalArticle

Abstract

This perspective on the report by Benchekroun et al. in this issue of the journal (beginning on page 800) examines new studies of factors in the epidermal growth factor receptor (EGFR) axis (including copy number alterations at the EGFR locus) that potentially predict the development of oral cancer; this work was conducted in a chemoprevention trial cohort of patients with oral premalignant lesions. The new data raise the possibility that a subset of oral premalignant lesions may benefit from specific therapeutic targeting of the EGFR axis.

Original languageEnglish (US)
Pages (from-to)797-799
Number of pages3
JournalCancer Prevention Research
Volume3
Issue number7
DOIs
StatePublished - Jul 2010

Fingerprint

Epidermal Growth Factor Receptor
Mouth Neoplasms
Chemoprevention
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The epidermal growth factor receptor axis : Support for a new target for oral premalignancy. / Rosin, Miriam P.; Califano, Joseph A.

In: Cancer Prevention Research, Vol. 3, No. 7, 07.2010, p. 797-799.

Research output: Contribution to journalArticle

Rosin, Miriam P. ; Califano, Joseph A. / The epidermal growth factor receptor axis : Support for a new target for oral premalignancy. In: Cancer Prevention Research. 2010 ; Vol. 3, No. 7. pp. 797-799.
@article{6ba75fcf682443df835292bb8f43b48b,
title = "The epidermal growth factor receptor axis: Support for a new target for oral premalignancy",
abstract = "This perspective on the report by Benchekroun et al. in this issue of the journal (beginning on page 800) examines new studies of factors in the epidermal growth factor receptor (EGFR) axis (including copy number alterations at the EGFR locus) that potentially predict the development of oral cancer; this work was conducted in a chemoprevention trial cohort of patients with oral premalignant lesions. The new data raise the possibility that a subset of oral premalignant lesions may benefit from specific therapeutic targeting of the EGFR axis.",
author = "Rosin, {Miriam P.} and Califano, {Joseph A.}",
year = "2010",
month = "7",
doi = "10.1158/1940-6207.CAPR-10-0114",
language = "English (US)",
volume = "3",
pages = "797--799",
journal = "Cancer Prevention Research",
issn = "1940-6207",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - The epidermal growth factor receptor axis

T2 - Support for a new target for oral premalignancy

AU - Rosin, Miriam P.

AU - Califano, Joseph A.

PY - 2010/7

Y1 - 2010/7

N2 - This perspective on the report by Benchekroun et al. in this issue of the journal (beginning on page 800) examines new studies of factors in the epidermal growth factor receptor (EGFR) axis (including copy number alterations at the EGFR locus) that potentially predict the development of oral cancer; this work was conducted in a chemoprevention trial cohort of patients with oral premalignant lesions. The new data raise the possibility that a subset of oral premalignant lesions may benefit from specific therapeutic targeting of the EGFR axis.

AB - This perspective on the report by Benchekroun et al. in this issue of the journal (beginning on page 800) examines new studies of factors in the epidermal growth factor receptor (EGFR) axis (including copy number alterations at the EGFR locus) that potentially predict the development of oral cancer; this work was conducted in a chemoprevention trial cohort of patients with oral premalignant lesions. The new data raise the possibility that a subset of oral premalignant lesions may benefit from specific therapeutic targeting of the EGFR axis.

UR - http://www.scopus.com/inward/record.url?scp=77954725485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954725485&partnerID=8YFLogxK

U2 - 10.1158/1940-6207.CAPR-10-0114

DO - 10.1158/1940-6207.CAPR-10-0114

M3 - Article

C2 - 20570884

AN - SCOPUS:77954725485

VL - 3

SP - 797

EP - 799

JO - Cancer Prevention Research

JF - Cancer Prevention Research

SN - 1940-6207

IS - 7

ER -